CIK: 1204361 - Address: 635 Davis Drive, Suite 300, Morrisville, NC 27560
30 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret2122743251511
P%wins505050100505058
S%ret11414391065
S%wins50505025252538

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/9/17 06:37
8/8/17
TRXCTransenterix Inc.DEHealthMdEqSurgical & Medical InstrumentKelley Willam NNCDP210.705803015050D
6/20/17 16:35
6/16/17
GNVCGenvec IncDEHealthDrugPharmaceutical PreparationsKelley Willam NMDDM.d63.80020D
11/16/15 07:55
11/12/15
TRXCTransenterix Inc.DEHealthMdEqSurgical & Medical InstrumentKelley Willam NNCDP.m562.80120New20D-65-20-31-6181335-4-6-1447-34-41
2/8/11 19:34
2/4/11
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADM.d18737.35058011D
4/5/10 14:18
4/1/10
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADM.d25350.60051638D
4/5/10 14:18
4/1/10
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADS.d-31462.800-5-388D
8/26/09 17:04
8/25/09
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADM.d16031.92052067D
8/26/09 17:04
8/25/09
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADS.d-34168.250-5-407D
5/26/09 16:59
5/22/09
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADS-21052.410-4-357D
3/11/09 19:48
3/10/09
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADM.d8821.94045411
3/11/09 14:31
9/24/02
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADP.m2736.53331New1B82021174371
5/7/08 18:38
5/5/08
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADS-26566.260-4-386D
3/20/08 18:03
3/18/08
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NCADM.d11629.06046210D
3/7/07 19:24
3/1/07
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDM.d4120.5902536D
3/7/07 19:24
3/1/07
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDS.dm-12663.010-2-266D
2/7/07 11:20
2/6/07
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADM.d8741.413321454D723510-13-1-3-1-1-2018186
2/7/07 11:20
2/6/07
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADS.d-8744.5333-2-364D723510-13-1-3-1-1-2018186
3/17/06 15:01
3/15/06
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDM.ad4120.2802655
3/17/06 15:01
3/15/06
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDS.ad-10753.250-2-285
3/15/06 21:15
3/15/06
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDM.d4120.2802655
3/15/06 21:15
3/15/06
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDS.d-10753.250-2-285
2/15/06 13:30
2/14/06
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADM.d6028.44332162344322132
2/15/06 13:30
2/14/06
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADS.d-6134.6233-2-34344322132
2/25/05 19:23
2/24/05
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDS-8669.000-1-224D
2/14/05 09:45
2/11/05
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADM.d4320.383322233D-38-37-3313-9-2311121116723
2/14/05 09:45
2/11/05
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADS.d-4329.1933-1-333D-38-37-3313-9-2311121116723
2/2/05 13:55
1/31/05
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDM.d3014.7802556D
2/19/04 19:43
2/17/04
BECBeckman Coulter IncDEElectrLabEqLaboratory Analytical InstrumKelley Willam NDM.d2612.78021234D
2/9/04 15:39
2/6/04
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADM.d3014.223326492D-7-2-6139621-10-2-1-8-39
2/9/04 15:39
2/6/04
MRKMerck & Co IncNJHealthDrugPharmaceutical PreparationsKelley Willam NPADS.d-10348.9533-2-462D-7-2-6139621-10-2-1-8-39

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact